BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability

Area of Science:

• Molecular Biology
• Genetics
• DNA Repair Mechanisms

Background:

• BRCA2 deficiency causes genomic instability, but the exact mechanisms remain unclear.
• Understanding DNA double-strand break (DSB) repair is crucial for cancer research.

Purpose of the Study:

• To elucidate the mechanisms underlying genomic instability in BRCA2-deficient cells.
• To investigate the role of DNA repair pathways, specifically nonhomologous end-joining (NHEJ), in BRCA2 deficiency.

Main Methods:

• Studied the impact of BRCA2 inactivation on RPA-coated single-stranded DNA (ssDNA) structures at resected DSBs.
• Investigated the involvement of classical (c)-NHEJ and alternative (alt)-NHEJ pathways, including 53BP1, RIF1, and Artemis.
• Assessed nuclear fragmentation and DSB intermediate stability in cells with varying gene knockouts.

Main Results:

• BRCA2 inactivation, but not RAD51, destabilizes RPA-coated ssDNA at resected DSBs, increasing nuclear fragmentation.
• This instability is exacerbated by aberrant activation of c-NHEJ and alt-NHEJ, mediated by the 53BP1-RIF1 pathway and Artemis.
• Loss of 53BP1, RIF1, or Artemis stabilizes DSB intermediates and preserves nuclear integrity in BRCA2-deficient cells.

Conclusions:

• BRCA2 antagonizes 53BP1, RIF1, and Artemis to prevent toxic NHEJ events and maintain genomic stability.
• This protective mechanism operates independently of RAD51.
• Targeting the 53BP1-RIF1-Artemis axis offers a potential strategy to mitigate genomic instability in BRCA2-deficient contexts.